Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Thallion Pharmaceuticals Inc V.TLN



TSXV:TLN - Post by User

Post by Everswanon Dec 23, 2009 9:00pm
305 Views
Post# 16615993

Tax loss not that bad

Tax loss not that bad
I expected the stock to tank below 0,09 today.
I guess tax loss pressure is less than what i expected.

I didn't expect so much buying interest ont the other hand.

Thallion is the most undervalued partnered biotech out there.

Bioniche has a market cap of 55M
Sembiosys has a market capt of 8M (on the verge of running out of cash)

Thallion is at 3M market cap.

It's a no brainer for me.
With Shigamabs deal, market will reprice this stock higher, closer to cash valuation.
Something like 0,50$ is not unlikely



Management did a wonderful job in getting Shigamabs deal!
<< Previous
Bullboard Posts
Next >>